{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:53:52Z","timestamp":1787032432849,"version":"build-2736575974"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>The aging population in the U.S. and other developed countries has led to a large increase in the number of patients suffering from degenerative diseases. Transplantation surgery has been a successful therapeutic option for certain patients; however, the availability of suitable donor organs and tissues significantly limits the number of patients who can benefit from this approach. Regenerative medicine has witnessed numerous recent and spectacular advances, making the repair or replacement of dysfunctional organs and tissues an achievable goal. Public-private partnerships and government policies and incentives would further catalyze the development of universally available donor tissues, resulting in broad medical and economic benefits. This article describes a Regenerative Medicine Grand Challenge that the Alliance for Regenerative Medicine recently shared with the White House's Office of Science and Technology Policy in response to a White House call to action in scientific disciplines suggesting that the development of \u201cuniversal donor tissues\u201d should be designated as a Regenerative Medicine Grand Challenge. Such a designation would raise national awareness of the potential of regenerative medicine to address the unmet needs of many diseases and would stimulate the scientific partnerships and investments in technology needed to expedite this goal. Here we outline key policy changes and technological challenges that must be addressed to achieve the promise of a major breakthrough in the treatment of degenerative disease. A nationalized effort and commitment to develop universal donor tissues could realize this goal within 10 years and along the way result in significant innovation in manufacturing technologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>Regenerative therapies, in which dysfunctional or degenerating cells, tissues, or organs are repaired or replaced, have the potential to cure chronic degenerative diseases. Such treatments are limited by a shortage of donor organs and tissues and the need for immune suppression to prevent rejection. This article proposes a 21st Century Grand Challenge that would address this significant medical need by coordinating a national effort to convene the multidisciplinary expertise needed to manufacture functional and engraftable cells, tissues, or organs that could be made available to any patient without significant risk of rejection\u2014so-called universal donor tissues.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5966\/sctm.2015-0180","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T23:00:23Z","timestamp":1448492423000},"page":"1-7","source":"Crossref","is-referenced-by-count":23,"title":["Challenging Regeneration to Transform Medicine"],"prefix":"10.1093","volume":"5","author":[{"given":"Ann","family":"Tsukamoto","sequence":"first","affiliation":[{"name":"StemCells, Inc., Newark, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart E.","family":"Abbot","sequence":"additional","affiliation":[{"name":"Celgene Cellular Therapeutics, Warren, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Kadyk","sequence":"additional","affiliation":[{"name":"California Institute for Regenerative Medicine, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie D.","family":"DeWitt","sequence":"additional","affiliation":[{"name":"California Institute for Regenerative Medicine, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V.","family":"Schaffer","sequence":"additional","affiliation":[{"name":"Department of Chemical and Biomolecular Engineering, University of California, Berkeley, Berkeley, California, USA"},{"name":"Department of Bioengineering, University of California, Berkeley, Berkeley, California, USA"},{"name":"Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Wertheim","sequence":"additional","affiliation":[{"name":"Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Whittlesey","sequence":"additional","affiliation":[{"name":"California Institute for Regenerative Medicine, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Werner","sequence":"additional","affiliation":[{"name":"Holland & Knight, Washington, D.C., USA"},{"name":"Alliance for Regenerative Medicine, Washington, D.C., USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"key":"2021122704440652700_R1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/bmb\/ldt034","article-title":"Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies","volume":"108","author":"Ratcliffe","year":"2013","journal-title":"Br Med Bull"},{"key":"2021122704440652700_R2"},{"key":"2021122704440652700_R3","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1242\/dev.092551","article-title":"Induced pluripotent stem cells in medicine and biology","volume":"140","author":"Takahashi","year":"2013","journal-title":"Development"},{"key":"2021122704440652700_R4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5966\/sctm.2015-0052","article-title":"Proceedings: Human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the California population: Evaluating matching in a multiethnic and admixed population","volume":"4","author":"Pappas","year":"2015","journal-title":"Stem Cells Translational Medicine"},{"key":"2021122704440652700_R5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/biot.201300120","article-title":"Engineering the extracellular matrix for clinical applications: Endoderm, mesoderm, and ectoderm","volume":"9","author":"Williams","year":"2014","journal-title":"Biotechnol J"},{"key":"2021122704440652700_R6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5966\/sctm.2014-0254","article-title":"Manufacturing road map for tissue engineering and regenerative medicine technologies","volume":"4","author":"Hunsberger","year":"2015","journal-title":"Stem Cells Translational Medicine"},{"key":"2021122704440652700_R7","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1172\/JCI61974","article-title":"Perspectives on whole-organ assembly: Moving toward transplantation on demand","volume":"122","author":"Soto-Gutierrez","year":"2012","journal-title":"J Clin Invest"},{"key":"2021122704440652700_R8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrg3764","article-title":"Investigating human disease using stem cell models","volume":"15","author":"Sterneckert","year":"2014","journal-title":"Nat Rev Genet"},{"key":"2021122704440652700_R9","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1002\/adma.201305506","article-title":"3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs","volume":"26","author":"Kolesky","year":"2014","journal-title":"Adv Mater"},{"key":"2021122704440652700_R10","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1101\/gad.226837.113","article-title":"Nanotechnology: Emerging tools for biology and medicine","volume":"27","author":"Wong","year":"2013","journal-title":"Genes Dev"},{"key":"2021122704440652700_R11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.stem.2014.09.013","article-title":"Revisiting the flight of Icarus: Making human organs from PSCs with large animal chimeras","volume":"15","author":"Rashid","year":"2014","journal-title":"Cell Stem Cell"},{"key":"2021122704440652700_R12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nbt.2329","article-title":"Lessons from human teratomas to guide development of safe stem cell therapies","volume":"30","author":"Cunningham","year":"2012","journal-title":"Nat Biotechnol"},{"key":"2021122704440652700_R13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12195-014-0333-z","article-title":"Developing defined and scalable 3D culture systems for culturing human pluripotent stem cells at high densities","volume":"7","author":"Lei","year":"2014","journal-title":"Cell Mol Bioeng"},{"key":"2021122704440652700_R14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.stem.2015.01.013","article-title":"Direct lineage reprogramming: Strategies, mechanisms, and applications","volume":"16","author":"Xu","year":"2015","journal-title":"Cell Stem Cell"},{"key":"2021122704440652700_R15","doi-asserted-by":"crossref","first-page":"a015529","DOI":"10.1101\/cshperspect.a015529","article-title":"Induction of tolerance through mixed chimerism","volume":"4","author":"Sachs","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2021122704440652700_R16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.stem.2013.08.003","article-title":"Toward the development of a global induced pluripotent stem cell library","volume":"13","author":"Turner","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2021122704440652700_R17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.iac.2010.03.003","article-title":"Purified hematopoietic stem cell transplantation: The next generation of blood and immune replacement","volume":"30","author":"Czechowicz","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"key":"2021122704440652700_R18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.03.009","article-title":"Stem cell imaging: From bench to bedside","volume":"14","author":"Nguyen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"2021122704440652700_R19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1242\/dmm.018499","article-title":"Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicine","volume":"8","author":"Srivastava","year":"2015","journal-title":"Dis Model Mech"},{"key":"2021122704440652700_R20","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1039\/C4CS00532E","article-title":"Quantum dots: Bright and versatile in vitro and in vivo fluorescence imaging biosensors","volume":"44","author":"Wegner","year":"2015","journal-title":"Chem Soc Rev"},{"key":"2021122704440652700_R21"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0180","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0180","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/5\/1\/1\/41866355\/stcltm_5_1_1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/5\/1\/1\/41866355\/stcltm_5_1_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T21:50:12Z","timestamp":1642542612000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/5\/1\/1-7\/6397800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,25]]},"published-print":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2015-0180","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,1,1]]},"published":{"date-parts":[[2015,11,25]]}}}